ANXA1 and neoplasm: Previously published data on anxA1 expression in tumor vasculature has established the presence of a membrane-bound, N-terminal–truncated form of anxA1 on the luminal membrane of tumor-associated endothelium, and anxA1 has been proposed as a vascular antitumor target [19–21].